Show simple item record

dc.contributor.authorBerg, A L
dc.contributor.authorArnadottir, M
dc.date.accessioned2010-08-23T09:35:06Z
dc.date.available2010-08-23T09:35:06Z
dc.date.issued2000-07-01
dc.date.submitted2010-07-23
dc.identifier.citationNephrol. Dial. Transplant. 2000, 15(7):940-2en
dc.identifier.issn0931-0509
dc.identifier.pmid10862626
dc.identifier.urihttp://hdl.handle.net/2336/110134
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractNo abstract available
dc.language.isoenen
dc.publisherOxford University Pressen
dc.relation.urlhttp://ndt.oxfordjournals.org/cgi/reprint/15/7/940.pdfen
dc.subject.meshAdrenocorticotropic Hormoneen
dc.subject.meshHumansen
dc.subject.meshKidney Diseasesen
dc.subject.meshLipoproteinsen
dc.subject.meshReference Valuesen
dc.titleACTH revisited--potential implications for patients with renal disease [editorial]en
dc.typeArticleen
dc.contributor.departmentDepartment of Nephrology, University Hospital, Lund, Sweden.en
dc.identifier.journalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Associationen
html.description.abstractNo abstract available


This item appears in the following Collection(s)

Show simple item record